Demant A/S

Common Name

Demant

Country

Denmark

Sector

Healthcare

Industry

Medical Devices

Employees

22,057

Ticker

DEMANT

Exchange

NASDAQ COPENHAGEN A/S

Website

www.demant.com

Description

Demant A/S is a global leader in the hearing healthcare industry, offering a comprehensive range of products and solutions to support individuals with hearing loss. Primarily known for its advanced he... Show more

Financial Statements of Demant

Below are the financial statements of Demant, including the income statement and balance sheet for the company's latest fiscal year. All figures are accurate, verifiable, and fully traceable to the original annual filing where disclosed.

Income Statement (as reported) Balance Sheet (as reported)

All figures in millions of DKK	2024	2023
Intangible assets	15,066^a	13,540^a
Property, plant and equipment	2,909^a	2,813^a
Lease assets	2,665^a	2,596^a
Investments in associates	363^a	728^a
Receivables from associates	193^a	277^a
Other investments	9^a	19^a
Customer loans	519^a	477^a
Other receivables	217^a	170^a
Deferred tax assets	588^a	542^a
Other non-current assets	4,554^a	4,809^a
Non-current assets	22,529^a	21,162^a
Inventories	2,500^a	2,845^a
Trade receivables	3,563^a	3,650^a
Receivables from associates	200^a	188^a
Income tax	78^a	236^a
Customer loans	155^a	191^a
Other receivables	454^a	378^a
Unrealised gains on financial contracts	31^a	60^a
Prepaid expenses	435^a	415^a
Cash	1,112^a	1,138^a
Assets held for sale	1,393^a	283^a
Current assets	9,921^a	9,384^a
Assets	32,450^a	30,546^a
Share capital	44^a	45^a
Other reserves	9,520^a	9,211^a
Equity attributable to Demant A/S' shareholders	9,564^a	9,256^a
Equity attributable to non-controlling interests	80^a	82^a
Equity	9,644^a	9,338^a
Borrowings	12,487^a	10,171^a
Lease liabilities	2,104^a	2,045^a
Deferred tax liabilities	634^a	633^a
Provisions	213^a	201^a
Other liabilities	461^a	661^a
Deferred income	812^a	635^a
Non-current liabilities	16,711^a	14,346^a
Borrowings	423^a	1,597^a
Lease liabilities	667^a	641^a
Trade payables	658^a	799^a
Payables to associates	0^a	1^a
Income tax	603^a	578^a
Provisions	93^a	77^a
Other liabilities	2,617^a	2,497^a
Unrealised losses on financial contracts	102^a	35^a
Deferred income	588^a	548^a
Liabilities related to assets held for sale	344^a	89^a
Current liabilities	6,095^a	6,862^a
Liabilities	22,806^a	21,208^a
Equity and liabilities	32,450^a	30,546^a

Verified Sources Behind Demant’s Financial Fundamentals Data

Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Demant’s data sources below and access millions more through our Disclosure Search.

a. Demant's Annual Report 2024

Trace every data point back to Demant’s disclosures

Sign up for Tracenable and access millions of corporate disclosures, including annual reports and sustainability filings from global companies, completely free of charge.

Real-Time & Standardized Financials

Access Standardized Financial Statements within Minutes of Disclosure

At Tracenable, we're exploring the launch of real-time standardized financial datafeeds and APIs covering global equities. Unlike limited and inconsistent XBRL parsing, our approach aims to deliver clean, comparable, and fully traceable data seconds after publication.

Could this solution support your investment or analytical workflows?

Explore Peer Companies

Welcome Back to Tracenable

Sign in to your account

Demant A/S

Financial Statements of Demant

Verified Sources Behind Demant’s Financial Fundamentals Data

Access Standardized Financial Statements within Minutes of Disclosure

Explore Peer Companies

GN Store Nord A/S

Ambu A/S

Ascendis Pharma A/S

H Lundbeck A/S

Novo Nordisk A/S

Coloplast A/S